Prozac and Lung hyperinflation - a phase IV clinical study of FDA data

Summary:

Lung hyperinflation is reported as a side effect among people who take Prozac (fluoxetine hydrochloride), especially for people who are female, 60+ old, also take Synthroid, and have Asthma.

The phase IV clinical study analyzes which people have Lung hyperinflation when taking Prozac. It is created by eHealthMe based on reports of 74,788 people who have side effects when taking Prozac from the FDA, and is updated regularly.

What is Prozac?

Prozac has active ingredients of fluoxetine hydrochloride. It is often used in depression. eHealthMe is studying from 82,988 Prozac users. Check the latest studies of Prozac.

What is Lung hyperinflation?

Lung hyperinflation (inspiration of more than normal) is found to be associated with 305 drugs and 273 conditions by eHealthMe. Check the latest studies of Lung hyperinflation.

On Jul, 17, 2026

74,788 people reported to have side effects when taking Prozac.
Among them, 24 people (0.03%) have Lung hyperinflation.

Among these 24 people:

What is the gender of people who have Lung hyperinflation when taking Prozac? *

female: 100 %
male: 0.0 %

What is the age of people who have Lung hyperinflation when taking Prozac? *

What are other drugs people take besides Prozac? *

What are other side effects people have besides Lung hyperinflation? *

Cough: 14 people, 58.33%
Wheezing (a high-pitched whistling sound made while you breath): 12 people, 50.00%
Pneumonia: 11 people, 45.83%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 9 people, 37.50%
Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 9 people, 37.50%
Lower Respiratory Tract Infection: 9 people, 37.50%
Itching: 9 people, 37.50%
Injection Site Urticaria (rash of round, red welts on the skin at injection site): 9 people, 37.50%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 9 people, 37.50%
Respiratory Disorder (respiratory disease): 9 people, 37.50%

What are the existing conditions these people have? *

Asthma: 11 people, 45.83%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 37.50%
Vitamin B12 Deficiency: 7 people, 29.17%
Nausea (feeling of having an urge to vomit): 2 people, 8.33%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.33%
Gait Disturbance: 2 people, 8.33%
Eye Pain: 2 people, 8.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.17%
Pain: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Prozac and have Lung hyperinflation?

- Check whether Lung hyperinflation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prozac:

Prozac (82,988 reports)

Browse all side effects of Prozac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung hyperinflation:

Lung hyperinflation (305 drugs)

Browse all the conditions that are associated with Lung hyperinflation:

Lung hyperinflation (273 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluoxetine hydrochloride (the active ingredients of Prozac) and Prozac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.